Author:
Moore Kerry,McKnight Amy Jayne,Craig David,O’Neill Francis
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology,Molecular Medicine
Reference58 articles.
1. Almeida Mdo, R. (2012). Glucocerebrosidase involvement in Parkinson disease and other synucleinopathies. Frontiers in Neurology, 3, 65.
2. Ardley, H. C., Scott, G. B., Rose, S. A., Tan, N. G., & Robinson, P. A. (2004). UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson’s disease. Journal of Neurochemistry, 90(2), 379–391.
3. Bajaj, A., Driver, J. A., & Schernhammer, E. S. (2010). Parkinson’s disease and cancer risk: A systematic review and meta-analysis. Cancer Causes & Control: CCC, 21(5), 697–707.
4. Bando, Y., Onuki, R., Katayama, T., Manabe, T., Kudo, T., Taira, K., et al. (2005). Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson’s disease and Huntington’s disease. Neurochemistry International, 46(1), 11–18.
5. Bell, C. G., Teschendorff, A. E., Rakyan, V. K., Maxwell, A. P., Beck, S., & Savage, D. A. (2010). Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Medical Genomics, 3, 33.
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献